Jill Marie Broadfoot - May 31, 2024 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
Chief Financial Officer
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
Stock symbol
LIFE
Transactions as of
May 31, 2024
Transactions value $
$8,950
Form type
4
Date filed
6/3/2024, 08:38 AM
Previous filing
Feb 6, 2024
Next filing
Jun 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common Stock Purchase $8.95K +5K +21.78% $1.79 28K May 31, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2,139 shares acquired on May 15, 2024 under the Company's 2015 Employee Purchase Plan.